JPH04235111A - Cosmetic - Google Patents
CosmeticInfo
- Publication number
- JPH04235111A JPH04235111A JP3002103A JP210391A JPH04235111A JP H04235111 A JPH04235111 A JP H04235111A JP 3002103 A JP3002103 A JP 3002103A JP 210391 A JP210391 A JP 210391A JP H04235111 A JPH04235111 A JP H04235111A
- Authority
- JP
- Japan
- Prior art keywords
- carnosine
- purified water
- salts
- homocarnosine
- component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 14
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 claims abstract description 32
- 108010087806 Carnosine Proteins 0.000 claims abstract description 30
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 claims abstract description 30
- CCLQKVKJOGVQLU-QMMMGPOBSA-N L-homocarnosine Chemical compound NCCCC(=O)N[C@H](C(O)=O)CC1=CNC=N1 CCLQKVKJOGVQLU-QMMMGPOBSA-N 0.000 claims abstract description 16
- 108700002498 homocarnosine Proteins 0.000 claims abstract description 16
- 150000003839 salts Chemical class 0.000 claims abstract description 10
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 8
- 239000000787 lecithin Substances 0.000 claims abstract description 7
- 235000010445 lecithin Nutrition 0.000 claims abstract description 7
- 229940067606 lecithin Drugs 0.000 claims abstract description 7
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 7
- 229920002683 Glycosaminoglycan Polymers 0.000 claims abstract description 6
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 abstract description 2
- 206010040849 Skin fissures Diseases 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 24
- 239000008213 purified water Substances 0.000 description 23
- -1 Alkanoyl homocarnosine Chemical compound 0.000 description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 16
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 16
- 239000008294 cold cream Substances 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 12
- 102000008186 Collagen Human genes 0.000 description 10
- 108010035532 Collagen Proteins 0.000 description 10
- 229920001436 collagen Polymers 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 239000003205 fragrance Substances 0.000 description 9
- 235000011187 glycerol Nutrition 0.000 description 8
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 8
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 8
- 229960002216 methylparaben Drugs 0.000 description 8
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 7
- 239000006210 lotion Substances 0.000 description 7
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 6
- ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 description 6
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 6
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 125000004432 carbon atom Chemical group C* 0.000 description 6
- 239000002884 skin cream Substances 0.000 description 6
- 229920002385 Sodium hyaluronate Polymers 0.000 description 5
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 235000019441 ethanol Nutrition 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 229940010747 sodium hyaluronate Drugs 0.000 description 5
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 5
- 239000001587 sorbitan monostearate Substances 0.000 description 5
- 235000011076 sorbitan monostearate Nutrition 0.000 description 5
- 229940035048 sorbitan monostearate Drugs 0.000 description 5
- 239000004166 Lanolin Substances 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- 235000013871 bee wax Nutrition 0.000 description 4
- 239000012166 beeswax Substances 0.000 description 4
- 239000004359 castor oil Substances 0.000 description 4
- 235000019438 castor oil Nutrition 0.000 description 4
- 239000003240 coconut oil Substances 0.000 description 4
- 235000019864 coconut oil Nutrition 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 4
- 229940039717 lanolin Drugs 0.000 description 4
- 235000019388 lanolin Nutrition 0.000 description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 4
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 4
- 229940058015 1,3-butylene glycol Drugs 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 125000005907 alkyl ester group Chemical group 0.000 description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 229940075507 glyceryl monostearate Drugs 0.000 description 3
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 2
- ODHCTXKNWHHXJC-UHFFFAOYSA-N 5-oxoproline Chemical compound OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- 235000002566 Capsicum Nutrition 0.000 description 2
- 240000008574 Capsicum frutescens Species 0.000 description 2
- 229920000045 Dermatan sulfate Polymers 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- 102000011782 Keratins Human genes 0.000 description 2
- 108010076876 Keratins Proteins 0.000 description 2
- BKAYIFDRRZZKNF-VIFPVBQESA-N N-acetylcarnosine Chemical compound CC(=O)NCCC(=O)N[C@H](C(O)=O)CC1=CN=CN1 BKAYIFDRRZZKNF-VIFPVBQESA-N 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N Propene Chemical group CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- 239000004288 Sodium dehydroacetate Substances 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 2
- 239000004204 candelilla wax Substances 0.000 description 2
- 235000013868 candelilla wax Nutrition 0.000 description 2
- 229940073532 candelilla wax Drugs 0.000 description 2
- 239000001390 capsicum minimum Substances 0.000 description 2
- 125000001589 carboacyl group Chemical group 0.000 description 2
- 239000004203 carnauba wax Substances 0.000 description 2
- 235000013869 carnauba wax Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 2
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 2
- 229960003415 propylparaben Drugs 0.000 description 2
- 235000019259 sodium dehydroacetate Nutrition 0.000 description 2
- 229940079839 sodium dehydroacetate Drugs 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- DSOWAKKSGYUMTF-GZOLSCHFSA-M sodium;(1e)-1-(6-methyl-2,4-dioxopyran-3-ylidene)ethanolate Chemical compound [Na+].C\C([O-])=C1/C(=O)OC(C)=CC1=O DSOWAKKSGYUMTF-GZOLSCHFSA-M 0.000 description 2
- 229940031439 squalene Drugs 0.000 description 2
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 229940098465 tincture Drugs 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 239000010497 wheat germ oil Substances 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- OEANUJAFZLQYOD-CXAZCLJRSA-N (2r,3s,4r,5r,6r)-6-[(2r,3r,4r,5r,6r)-5-acetamido-3-hydroxy-2-(hydroxymethyl)-6-methoxyoxan-4-yl]oxy-4,5-dihydroxy-3-methoxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](OC)O[C@H](CO)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](OC)[C@H](C(O)=O)O1 OEANUJAFZLQYOD-CXAZCLJRSA-N 0.000 description 1
- GVJHHUAWPYXKBD-QLVXXPONSA-N (S,R,R)-alpha-tocopherol Chemical compound [H][C@@](C)(CCCC(C)C)CCC[C@@]([H])(C)CCC[C@@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2C GVJHHUAWPYXKBD-QLVXXPONSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 229920002971 Heparan sulfate Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229920000288 Keratan sulfate Polymers 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 102000015728 Mucins Human genes 0.000 description 1
- 108010063954 Mucins Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 229940092738 beeswax Drugs 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 229940082483 carnauba wax Drugs 0.000 description 1
- 229940044199 carnosine Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- 229940094517 chondroitin 4-sulfate Drugs 0.000 description 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 description 1
- 229940051593 dermatan sulfate Drugs 0.000 description 1
- QTBSBXVTEAMEQO-DYCDLGHISA-N deuterio acetate Chemical compound [2H]OC(C)=O QTBSBXVTEAMEQO-DYCDLGHISA-N 0.000 description 1
- VFNGKCDDZUSWLR-UHFFFAOYSA-L disulfate(2-) Chemical compound [O-]S(=O)(=O)OS([O-])(=O)=O VFNGKCDDZUSWLR-UHFFFAOYSA-L 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 239000000118 hair dye Substances 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- KXCLCNHUUKTANI-RBIYJLQWSA-N keratan Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@H](COS(O)(=O)=O)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H]([C@@H](COS(O)(=O)=O)O[C@@H](O)[C@@H]3O)O)[C@H](NC(C)=O)[C@H]2O)COS(O)(=O)=O)O[C@H](COS(O)(=O)=O)[C@@H]1O KXCLCNHUUKTANI-RBIYJLQWSA-N 0.000 description 1
- 150000003893 lactate salts Chemical class 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 239000007934 lip balm Substances 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- HLERILKGMXJNBU-UHFFFAOYSA-N norvaline betaine Chemical compound CCCC(C([O-])=O)[N+](C)(C)C HLERILKGMXJNBU-UHFFFAOYSA-N 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 229940056211 paraffin Drugs 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229940057847 polyethylene glycol 600 Drugs 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 150000003892 tartrate salts Chemical class 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- UGZADUVQMDAIAO-UHFFFAOYSA-L zinc hydroxide Chemical class [OH-].[OH-].[Zn+2] UGZADUVQMDAIAO-UHFFFAOYSA-L 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】0001
【産業上の利用分野】本発明は優れた肌荒れ改善作用を
有する化粧料に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to cosmetics having an excellent effect on improving rough skin.
【0002】0002
【従来の技術】L−カルノシンまたはその塩を配合した
皮膚化粧料は知られている(特開平2−221213号
公報)、化粧料の原料としてムコ多糖類(特公平2−7
287号公報)、可溶性ペプチド(特開昭60−116
617号公報)、レシチン(特開昭62−298509
号公報)を用いることは知られている。又、ホモカルノ
シンが抗腫瘍剤の有効成分であることは知られている(
特開昭60−16926号公報)。[Prior Art] Skin cosmetics containing L-carnosine or its salts are known (Japanese Unexamined Patent Application Publication No. 2-221213), and mucopolysaccharide (Japanese Patent Publication No. 2-7
No. 287), soluble peptide (Japanese Unexamined Patent Publication No. 116/1986)
No. 617), lecithin (Japanese Unexamined Patent Publication No. 62-298509)
It is known to use the following. It is also known that homocarnosine is an active ingredient of antitumor agents (
(Japanese Unexamined Patent Publication No. 16926/1983).
【0003】0003
【発明が解決しようとする課題】本発明は優れた肌荒れ
改善作用を有する化粧料を提供することを目的とする。SUMMARY OF THE INVENTION An object of the present invention is to provide a cosmetic having an excellent effect on improving rough skin.
【0004】0004
【課題を解決するための手段】本発明はL−カルノシン
もしくはその誘導体、ホモカルノシンもしくはその誘導
体及びそれらの塩からなる群より選ばれた少なくとも1
種とムコ多糖類、可溶性ペプチド及びレシチンからなる
群より選ばれた少なくとも1種とを含有する化粧料に関
する。[Means for Solving the Problems] The present invention provides at least one member selected from the group consisting of L-carnosine or its derivatives, homocarnosine or its derivatives, and salts thereof.
The present invention relates to a cosmetic containing seeds and at least one selected from the group consisting of mucopolysaccharides, soluble peptides, and lecithin.
【0005】L−カルノシンまたはホモカルノシンの誘
導体としてはL−カルノシンまたはホモカルノシンの炭
素数1〜5のアルカノイル、炭素数1〜5のアルキルエ
ステル等があげられる。炭素数1〜5のアルカノイルと
してはホルミル、アセチル、プロピオニル、ブチリル、
バレリル等があげられ、炭素数1〜5のアルキルとして
は、メチル、エチル、プロピル、イソプロピル、ブチル
、ペンチル等があげられる。Examples of derivatives of L-carnosine or homocarnosine include alkanoyl having 1 to 5 carbon atoms and alkyl ester having 1 to 5 carbon atoms of L-carnosine or homocarnosine. Alkanoyl having 1 to 5 carbon atoms includes formyl, acetyl, propionyl, butyryl,
Examples of the alkyl group having 1 to 5 carbon atoms include valeryl, methyl, ethyl, propyl, isopropyl, butyl, and pentyl.
【0006】炭素数1〜5のアルカノイル−L−カルノ
シンは公知化合物である(特開昭58−124750号
公報)。炭素数1〜5のアルカノイルホモカルノシンは
L−カルノシンの代わりにホモカルノシンを用いて特開
昭58−124750号公報に記載した方法と同様にし
て得ることができる。L−カルノシン及びホモカルノシ
ンのアルキルエステルはL−カルノシン及びホモカルノ
シンを原料としてペプタイドのアルキルエステルを得る
方法(WO88/00182)と同様にして得ることが
できる。Alkanoyl-L-carnosine having 1 to 5 carbon atoms is a known compound (Japanese Unexamined Patent Publication No. 124750/1983). Alkanoyl homocarnosine having 1 to 5 carbon atoms can be obtained in the same manner as the method described in JP-A-58-124750, using homocarnosine instead of L-carnosine. Alkyl esters of L-carnosine and homocarnosine can be obtained in the same manner as the method for obtaining alkyl esters of peptides using L-carnosine and homocarnosine as raw materials (WO 88/00182).
【0007】L−カルノシン、ホモカルノシン及びこれ
らの誘導体の塩としてはこれらの金属塩(ナトリウム塩
、カリウム塩、カルシウム塩、マグネシウム塩、亜鉛塩
、アルミニウム塩等)、アンモニウム塩、水酸化金属塩
(水酸化亜鉛塩等)、無機酸塩(塩酸塩、硫酸塩、硝酸
塩、リン酸塩等)、有機酸塩(酢酸塩、乳酸塩、酒石酸
塩、クエン酸塩等)があげられる。L−カルノシンの塩
及びホモカルノシンの塩を得る方法は特開平2−221
213号公報及び特開昭60−16926号公報にそれ
ぞれ記載されており、又L−カルノシン及びホモカルノ
シンの誘導体の塩は前記公報に記載の方法と同様にして
得ることができる。Salts of L-carnosine, homocarnosine and their derivatives include their metal salts (sodium salts, potassium salts, calcium salts, magnesium salts, zinc salts, aluminum salts, etc.), ammonium salts, hydroxide metal salts ( Zinc hydroxide salts, etc.), inorganic acid salts (hydrochlorides, sulfates, nitrates, phosphates, etc.), and organic acid salts (acetates, lactates, tartrates, citrates, etc.). A method for obtaining L-carnosine salt and homocarnosine salt is disclosed in JP-A-2-221.
The salts of derivatives of L-carnosine and homocarnosine can be obtained in the same manner as described in the above-mentioned publications.
【0008】ムコ多糖類としては、ヒアルロン酸もしく
はその塩(ナトリウム塩、カリウム塩、アミノ酸塩等)
、ヒアルロン酸蛋白複合体、コンドロイチン4硫酸、コ
ンドロイチン6硫酸、コンドロイチン 4,6ジ硫酸、
デルマタン硫酸、デルマタン4,6 ジ硫酸、ケラタン
硫酸、ヘパラン硫酸等があげられる。可溶性ペプチドと
しては、可溶性コラーゲン、可溶性エラスチン、ムチン
、ケラチン、カゼイン加水分解物、シルク加水分解物等
があげられる。[0008] As mucopolysaccharides, hyaluronic acid or its salts (sodium salt, potassium salt, amino acid salt, etc.)
, hyaluronic acid protein complex, chondroitin 4-sulfate, chondroitin 6-sulfate, chondroitin 4,6-disulfate,
Examples include dermatan sulfate, dermatan 4,6 disulfate, keratan sulfate, heparan sulfate, and the like. Examples of soluble peptides include soluble collagen, soluble elastin, mucin, keratin, casein hydrolyzate, silk hydrolyzate, and the like.
【0009】レシチンとしては、大豆レシチン、卵黄レ
シチン、水添レシチン、リゾレシチン等があげられる。
化粧料中のL−カルノシンもしくはその誘導体、ホモカ
ルノシンもしくはその誘導体及びそれらの塩の配合量は
通常0.01〜10重量%であり、ムコ多糖類、可溶性
ペプチド及びレシチンの配合量は通常0.005 〜5
重量%である。Examples of lecithin include soybean lecithin, egg yolk lecithin, hydrogenated lecithin, and lysolecithin. The amount of L-carnosine or its derivatives, homocarnosine or its derivatives, and their salts in cosmetics is usually 0.01 to 10% by weight, and the amount of mucopolysaccharides, soluble peptides, and lecithin is usually 0.01 to 10% by weight. 005 ~5
Weight%.
【0010】本発明の化粧料の他の成分としては例えば
油分(蜜ロウ、キャンデリラロウ、カルナバロウ等のロ
ウ、パラフィン、ラノリン、セタノール、スクワレン、
小麦胚芽油、ステアリン酸、ステアリルアルコール、セ
レシン、ワックス等)、界面活性剤(モノステアリン酸
グリセリン、モノステアリン酸ソルビタン、ポリオキシ
エチレンステアリルエーテル、ソルビタンモノステアレ
ート、ポリオキシエチレンソルビタンモノステアレート
、ポリオキシエチレンソルビタントリオレート、ポリオ
キシエチレンラウリルエーテル硫酸ナトリウム、ヤシ油
脂肪酸アミドプロピルベタイン、デヒドロ酢酸ナトリウ
ム、ヤシ油脂肪ジエタノールアミド、ポリオキシエチレ
ン硬化ヒマシ油、トリ−2−エチルヘキサン酸グリセリ
ン等)、防腐剤(メチルパラベン、エチルパラベン、プ
ロピルパラベン等)、栄養剤(トウガラシチンキ、アラ
ントイン等)、保湿剤(グリセリン、プロピレングリコ
ール、ポリプロピレングリコール、ピロリドンカルボン
酸、 1,3−ブチレングリコール等)、増粘剤(カル
ボキシビニルポリマー、ポリエチレングリコール、ポリ
ビニルアルコール等)、アルコール(エチルアルコール
等)、アルカリ(水酸化カリウム、水酸化ナトリウム等
)、有機酸(クエン酸等)、酸化防止剤(ブチルハイド
ロキシアニソール等)、香料、精製水等が用いられる。Other ingredients of the cosmetic of the present invention include oils (waxes such as beeswax, candelilla wax, and carnauba wax, paraffin, lanolin, cetanol, squalene,
wheat germ oil, stearic acid, stearyl alcohol, ceresin, wax, etc.), surfactants (glyceryl monostearate, sorbitan monostearate, polyoxyethylene stearyl ether, sorbitan monostearate, polyoxyethylene sorbitan monostearate, (oxyethylene sorbitan triolate, sodium polyoxyethylene lauryl ether sulfate, coconut oil fatty acid amidopropyl betaine, sodium dehydroacetate, coconut oil fatty diethanolamide, polyoxyethylene hydrogenated castor oil, glycerin tri-2-ethylhexanoate, etc.), preservatives agents (methylparaben, ethylparaben, propylparaben, etc.), nutritional agents (capsicum tincture, allantoin, etc.), humectants (glycerin, propylene glycol, polypropylene glycol, pyrrolidone carboxylic acid, 1,3-butylene glycol, etc.), thickeners ( carboxyvinyl polymer, polyethylene glycol, polyvinyl alcohol, etc.), alcohol (ethyl alcohol, etc.), alkali (potassium hydroxide, sodium hydroxide, etc.), organic acid (citric acid, etc.), antioxidant (butyl hydroxyanisole, etc.), fragrance , purified water, etc. are used.
【0011】本発明の化粧料は種々の形態、例えば、軟
膏、溶液、固型等の形態で各種クリーム(コールドクリ
ーム、スキンクリーム、リップクリーム等)、化粧水、
乳液、ゼリー、パック等として製造される。以下に本発
明の化粧料の効果を示す試験例を示す。The cosmetics of the present invention can be used in various forms such as ointments, solutions, and solid forms such as various creams (cold creams, skin creams, lip balms, etc.), lotions, lotions, etc.
Manufactured as emulsion, jelly, pack, etc. Test examples showing the effects of the cosmetics of the present invention are shown below.
【0012】試験例1
コールドクリームの比較試験
荒れ肌、しわに悩む女性32名を8人ずつの4群に分け
、実施例1のコールドクリームを顔面の左半分に、比較
例1〜4のコールドクリームを顔面の右半分にそれぞれ
1日1もしくは2回塗布した。1ヶ月後の結果について
第1表に示す。Test Example 1 Cold Cream Comparison Test Thirty-two women suffering from rough skin and wrinkles were divided into four groups of eight people each, and the cold cream of Example 1 was applied to the left half of the face, and the cold creams of Comparative Examples 1 to 4 were applied to the left half of the face. Each was applied to the right half of the face once or twice a day. Table 1 shows the results after one month.
【0013】試験例2
乳液の比較試験
試験例1において実施例1及び比較例1〜4のコールド
クリームの代わりに実施例2及び比較例5〜8の乳液を
用いる以外は試験例1と同様に行った。その結果を第1
表に示す。Test Example 2 Comparative test of emulsions The same procedure as in Test Example 1 was carried out except that the emulsions of Example 2 and Comparative Examples 5 to 8 were used instead of the cold creams of Example 1 and Comparative Examples 1 to 4. went. The result is the first
Shown in the table.
【0014】試験例3
スキンクリームの比較試験
試験例1において実施例1及び比較例1〜4のコールド
クリームの代わりに実施例3及び比較例9〜12のスキ
ンクリームを用いる以外は試験例1と同様に行った。そ
の結果を第1表に示す。Test Example 3 Comparative test of skin cream Test Example 1 was performed except that the skin creams of Example 3 and Comparative Examples 9 to 12 were used instead of the cold creams of Example 1 and Comparative Examples 1 to 4. I did the same. The results are shown in Table 1.
【0015】[0015]
【表1】[Table 1]
【0016】表から明らかな如く、大多数の人が実施例
の化粧料の方を良好とした。As is clear from the table, the majority of people found the cosmetics of Examples to be better.
【0017】[0017]
【実施例】以下に実施例及び比較例を示す。尚、実施例
及び比較例に示す%は重量%を意味する。[Example] Examples and comparative examples are shown below. Note that % shown in Examples and Comparative Examples means % by weight.
【0018】実施例1
(%) (A)流動パラフィン
30.0
蜜ロウ
5
.0 ラノリン
5.0 セタノール
2.0 自己乳化型モノステアリン
酸グリセリン 3.5
モノステアリン酸ソルビタン
1.5 (B)可溶性コラーゲン
1.0 L−カルノシン
0.2 メチルパラベン
0.2 濃グリセリン
3.0 カルボキシビニルポリマー
0.5
水酸化カリウム
0.2
精製水
47.7
(C)香料
0.
280℃で加熱融解した(A)成分に80℃で加熱溶解
した(B)成分を添加してホモミキサーで乳化した。つ
いで、50℃まで冷却した後、(C)成分を添加し、室
温まで冷却しコールドクリームを得た。Example 1
(%) (A) Liquid paraffin
30.0
beeswax
5
.. 0 lanolin
5.0 Setanol
2.0 Self-emulsifying glyceryl monostearate 3.5
Sorbitan monostearate
1.5 (B) Soluble collagen
1.0 L-carnosine
0.2 Methylparaben
0.2 concentrated glycerin
3.0 Carboxyvinyl polymer
0.5
potassium hydroxide
0.2
purified water
47.7
(C) Fragrance
0.
Component (B) heated and dissolved at 80° C. was added to component (A) heated and melted at 280° C., and emulsified with a homomixer. Then, after cooling to 50°C, component (C) was added, and the mixture was cooled to room temperature to obtain cold cream.
【0019】比較例1〜4
実施例1において、L−カルノシン 0.2%、可溶性
コラーゲン 1.0%及び精製水47.7%の代わりに
第2表に示すL−カルノシンもしくは可溶性コラーゲン
及び精製水を用いる以外は実施例1と同様にしてコール
ドクリームを得た。Comparative Examples 1 to 4 In Example 1, L-carnosine or soluble collagen shown in Table 2 and purified water were used instead of 0.2% L-carnosine, 1.0% soluble collagen, and 47.7% purified water. Cold cream was obtained in the same manner as in Example 1 except that water was used.
【0020】[0020]
【表2】[Table 2]
【0021】実施例2
(%) (A)スクワレン
4.0 小麦胚芽油
2.0 蜜ロウ
2.5 グリセリルモノステア
レート 1.0
ポリオキシエチレン(20モル)
ステアリルエーテル
4.0 プロピル
パラベン
0.1 (B)メチルパラベン
0.1 プロピレングリコール
6.0 ポリエチレングリコール600
0 0.2
ヒアルロン酸ナトリウム
0.1 L−カ
ルノシン
0.5 精製水
79.3 (C)香料
0.280℃で加熱融解
した(A)成分に80℃で加熱溶解した(B)成分を添
加してホモミキサーで乳化した。ついで、50℃まで冷
却した後、(C)成分を添加し、室温まで冷却し乳液を
得た。Example 2
(%) (A) Squalene
4.0 Wheat germ oil
2.0 Beeswax
2.5 Glyceryl monostearate 1.0
Polyoxyethylene (20 moles)
stearyl ether
4.0 Propylparaben
0.1 (B) Methylparaben
0.1 Propylene glycol
6.0 Polyethylene glycol 600
0 0.2
Sodium hyaluronate
0.1 L-carnosine
0.5 Purified water
79.3 (C) Fragrance
Component (B) heated and dissolved at 80° C. was added to component (A) heated and melted at 0.280° C., and emulsified with a homomixer. After cooling to 50° C., component (C) was added, and the mixture was cooled to room temperature to obtain a milky lotion.
【0022】比較例5〜8
実施例2において、L−カルノシン 0.5%、ヒアル
ロン酸ナトリウム0.1%及び精製水79.3%の代わ
りに第2表に示すL−カルノシンもしくはヒアルロン酸
ナトリウム及び精製水を用いる以外は実施例2と同様に
して乳液を得た。Comparative Examples 5 to 8 In Example 2, L-carnosine or sodium hyaluronate shown in Table 2 was used instead of 0.5% L-carnosine, 0.1% sodium hyaluronate, and 79.3% purified water. A milky lotion was obtained in the same manner as in Example 2 except that purified water was used.
【0023】実施例3
(%) (A)蜜ロウ
2.0 ステアリン酸
5.0 ステアリルアルコール
5.
0 還元ラノリン
2.
0 スクワラン
20
.0 ソルビタンモノステアレート
8.0
ポリオキシエチレン(20モル)
ソル
ビタンモノステアレート
5.0 ポリオキシエチレン(20モ
ル)
ソルビタントリオレート
3.0 リゾ
レシチン
0.4 (B)L−カルノ
シン
0.2 グリセリン
6.1 メチルパラ
ベン
0.2 精製水
42.9 (C)香料
0.280℃で加熱融解した
(A)成分に80℃で加熱溶解した(B)成分を添加し
てホモミキサーで乳化した。ついで、50℃まで冷却し
た後、(C)成分を添加し、室温まで冷却しスキンクリ
ームを得た。Example 3
(%) (A) Beeswax
2.0 Stearic acid
5.0 Stearyl alcohol
5.
0 reduced lanolin
2.
0 squalane
20
.. 0 Sorbitan monostearate
8.0
Polyoxyethylene (20 moles)
sorbitan monostearate
5.0 Polyoxyethylene (20 mol)
sorbitan triolate
3.0 Lysolecithin
0.4 (B) L-carnosine
0.2 Glycerin
6.1 Methylparaben
0.2 Purified water
42.9 (C) Fragrance
Component (B) heated and dissolved at 80° C. was added to component (A) heated and melted at 0.280° C., and emulsified with a homomixer. Then, after cooling to 50°C, component (C) was added, and the mixture was cooled to room temperature to obtain a skin cream.
【0024】比較例9〜12
実施例3において、L−カルノシン 0.2%、リゾレ
シチン 0.4%及び精製水42.9%の代わりに第2
表に示すL−カルノシンもしくはリゾレシチン及び精製
水を用いる以外は実施例3と同様にしてスキンクリーム
を得た。Comparative Examples 9 to 12 In Example 3, L-carnosine 0.2%, lysolecithin 0.4% and purified water 42.9% were replaced with
A skin cream was obtained in the same manner as in Example 3, except that L-carnosine or lysolecithin and purified water shown in the table were used.
【0025】実施例4
実施例1において、可溶性コラーゲン1%(w/w)の
代わりに可溶性コラーゲン0.9(%)及び可溶性エラ
スチン 0.1(%)を用いる以外は実施例1と同様に
してコールドクリームを得た。Example 4 The procedure of Example 1 was repeated except that 0.9 (%) of soluble collagen and 0.1 (%) of soluble elastin were used instead of 1% (w/w) of soluble collagen. I got cold cream.
【0026】実施例5
実施例1において、可溶性コラーゲン1%の代わりに可
溶性コラーゲン 0.9%及びムチン 0.1%を用い
る以外は実施例1と同様にしてコールドクリームを得た
。Example 5 A cold cream was obtained in the same manner as in Example 1 except that 0.9% soluble collagen and 0.1% mucin were used instead of 1% soluble collagen.
【0027】実施例6
(%) (A)ポリオキシエチレンラウリル
エーテル硫酸ナトリウム30%溶液
35.0 ヤシ油脂
肪酸アミド
プロピルベタイン30%溶液
9.0
メチルパラベン
0.2
デヒドロ酢酸ナトリウム
0.1 ヤシ油脂肪
酸ジエタノールアミド
1.0 ポリプロピレングリコール
1.0
ケラチン
0.1
L−カルノシン
0.2
クエン酸
0.3
精製水
5
2.9 (B)香料
0.2(A)成分を70℃で溶解した後、50℃まで
冷却し、これに(B)成分を添加して先髪料を得た。Example 6
(%) (A) Polyoxyethylene lauryl
Ether sodium sulfate 30% solution
35.0 Coconut oil fatty acid amide propyl betaine 30% solution 9.0
Methylparaben
0.2
Sodium dehydroacetate
0.1 Coconut oil fatty acid diethanolamide
1.0 Polypropylene glycol
1.0
keratin
0.1
L-carnosine
0.2
citric acid
0.3
purified water
5
2.9 (B) Fragrance
0.2 Component (A) was dissolved at 70°C, cooled to 50°C, and component (B) was added thereto to obtain a hair dye.
【0028】実施例7
(%) (A)D−パントテニルアルコール
0.2
ヒアルロン酸ナトリウム
0.01 L−
カルノシン
0.2 トウガ
ラシチンキ
0.5 精製水
51.99 (B)酢酸d
l−α−トコフェロール
0.2 l−メントール
0.2 ポリオキシエチレン(
60モル) 硬化ヒマシ油
1.5 エチルアルコール
4
5.0 香料
0.2溶解した(A)成分に溶解した(B)成
分を添加した後、濾過して養毛剤を得た。Example 7
(%) (A) D-pantothenyl alcohol
0.2
Sodium hyaluronate
0.01 L-
carnosine
0.2 Capsicum tincture
0.5 Purified water
51.99 (B) Acetic acid d
l-α-tocopherol
0.2 l-menthol
0.2 Polyoxyethylene (
60 moles) hydrogenated castor oil
1.5 Ethyl alcohol
4
5.0 Fragrance
After adding the dissolved component (B) to the dissolved component (A), the mixture was filtered to obtain a hair tonic.
【0029】実施例8
(%) (A)クエン酸
0
.02 クエン酸ナトリウム
0.
2 dl−ピロリドンカルボン酸
0.2
1,3−ブチレングリコール
4.0 メチル
パラベン
0.1 L−カル
ノシン
0.1 精製水
84.28 (B)リゾレ
シチン
0.125 グ
リセリン
0.375
ポリオキシエチレン(60モル)
硬化ヒマシ油
0.5
香料
0.1
エチルアルコール
10.065℃で溶解
した(A)成分に65℃で溶解した(B)成分を添加し
た後、室温まで冷却し化粧水を得た。Example 8
(%) (A) Citric acid
0
.. 02 Sodium citrate
0.
2 dl-pyrrolidonecarboxylic acid
0.2
1,3-butylene glycol
4.0 Methylparaben
0.1 L-carnosine
0.1 Purified water
84.28 (B) Lysolecithin
0.125 Glycerin
0.375
Polyoxyethylene (60 mol)
hydrogenated castor oil
0.5
fragrance
0.1
Ethyl alcohol
Component (B) dissolved at 65° C. was added to component (A) dissolved at 10.065° C., and then cooled to room temperature to obtain a lotion.
【0030】実施例9
(%) (A)キャンデリラロウ
10.0
カルナバロウ
4.0
セレシン
3.0
マイクロクリスタリンワックス
3.0
ラノリン
10.0
流動パラフィン
10.0
トリ−2−エチルヘキサン酸グリセリン
38.5 ブチルハイドロキシアニ
ソール 0.1
(B)ヒマシ油
20.0
酸化チタン
1.0
可溶性コラーゲン
0.1
L−カルノシン
0.1
香料
0.27
0℃で加熱溶解した(A)成分に70℃で加熱溶解した
(B)成分を加え混合した後、ローラミルで分散した。
これを型に流し込んだ後、急冷してリップクリームを得
た。Example 9
(%) (A) Candelilla wax
10.0
carnauba wax
4.0
Ceresin
3.0
microcrystalline wax
3.0
lanolin
10.0
liquid paraffin
10.0
Glycerin tri-2-ethylhexanoate
38.5 Butyl hydroxyanisole 0.1
(B) Castor oil
20.0
titanium oxide
1.0
soluble collagen
0.1
L-carnosine
0.1
fragrance
0.27
Component (B) heated and dissolved at 70° C. was added to component (A) heated and dissolved at 0° C., mixed, and then dispersed with a roller mill. After pouring this into a mold, it was rapidly cooled to obtain a lip balm.
【0031】実施例10
(%) (A)ポリビニルアルコール
12.0
メチルパラベン
0.1
エチルアルコール
8.0
香料
0.2 (
B)ヒアルロン酸ナトリウム
0.2 L−カ
ルノシン
0.2 濃グリセ
リン
4.0 dl−ピ
ロリドンカルボン酸
0.2 アラントイン
0.1 精製水
75.070℃で加熱溶解した(B)成
分に70℃で加熱溶解した(A)成分を加え混合した後
、室温まで冷却しパックを得た。Example 10
(%) (A) Polyvinyl alcohol
12.0
Methylparaben
0.1
Ethyl alcohol
8.0
fragrance
0.2 (
B) Sodium hyaluronate
0.2 L-carnosine
0.2 concentrated glycerin
4.0 dl-pyrrolidonecarboxylic acid
0.2 Allantoin
0.1 Purified water
Component (A) heated and dissolved at 70° C. was added to component (B) heated and dissolved at 75.070° C., mixed, and then cooled to room temperature to obtain a pack.
【0032】実施例11
(%) 可溶性コラーゲン
2.
0 L−カルノシン
0.2
1,3−ブチレングリコール
1.0 メチル
パラベン
0.1 精製水
96.7全体を均一
に溶解した後、型に流し込み、凍結乾燥してフィルム状
パックを得た。Example 11
(%) Soluble collagen
2.
0 L-carnosine
0.2
1,3-butylene glycol
1.0 Methylparaben
0.1 Purified water
After uniformly dissolving the entire 96.7, it was poured into a mold and freeze-dried to obtain a film pack.
【0033】実施例12
実施例3において、リゾレシチン 0.4%、グリセリ
ン 6.1%及び精製水42.9%の代わりにレシチン
0.2%、プロピレングリコール 5.0%及び精製
水44.2%を用いる以外は実施例3と同様にしてスキ
ンクリームを得た。Example 12 In Example 3, 0.2% lecithin, 5.0% propylene glycol, and 44.2% purified water were used instead of 0.4% lysolecithin, 6.1% glycerin, and 42.9% purified water. A skin cream was obtained in the same manner as in Example 3 except that % was used.
【0034】実施例13
実施例1においてL−カルノシンの代わりにN−アセチ
ル−L−カルノシンを用いる以外は実施例1と同様にし
てコールドクリームを得た。Example 13 A cold cream was obtained in the same manner as in Example 1 except that N-acetyl-L-carnosine was used instead of L-carnosine.
【0035】実施例14
実施例8において、L−カルノシンの代わりにN−アセ
チル−L−カルノシンを用いる以外は実施例8と同様に
して化粧水を得た。Example 14 A lotion was obtained in the same manner as in Example 8 except that N-acetyl-L-carnosine was used instead of L-carnosine.
【0036】実施例15
実施例2において、L−カルノシン 0.5%及び精製
水79.3%の代わりにホモカルノシン 0.1%及び
精製水79.7%を用いる以外は実施例2と同様にして
乳液を得た。Example 15 Same as Example 2 except that 0.1% of homocarnosine and 79.7% of purified water were used instead of 0.5% of L-carnosine and 79.3% of purified water. A milky lotion was obtained.
【0037】実施例16
実施例1において、L−カルノシン 0.2%及び精製
水47.7%の代わりにホモカルノシン0.05%及び
精製水47.85 %を用いる以外は実施例1と同様に
してコールドクリームを得た。Example 16 Same as Example 1 except that 0.05% of homocarnosine and 47.85% of purified water were used instead of 0.2% of L-carnosine and 47.7% of purified water. Then you got cold cream.
【0038】実施例17
実施例7において、L−カルノシン 0.2%及び精製
水51.99 %の代わりにホモカルノシン 0.1%
及び精製水52.09 %を用いる以外は実施例7と同
様にして養毛剤を得た。Example 17 In Example 7, 0.1% homocarnosine was used instead of 0.2% L-carnosine and 51.99% purified water.
A hair tonic was obtained in the same manner as in Example 7 except that 52.09% of purified water was used.
【0039】[0039]
【発明の効果】本発明の化粧料は優れた肌荒れ改善作用
を有する。Effects of the Invention The cosmetic composition of the present invention has an excellent effect on improving rough skin.
Claims (1)
ホモカルノシンもしくはその誘導体及びそれらの塩から
なる群より選ばれた少なくとも1種とムコ多糖類、可溶
性ペプチド及びレシチンからなる群より選ばれた少なく
とも1種とを含有する化粧料。[Claim 1] L-carnosine or a derivative thereof,
A cosmetic containing at least one member selected from the group consisting of homocarnosine, derivatives thereof, and salts thereof, and at least one member selected from the group consisting of mucopolysaccharides, soluble peptides, and lecithin.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3002103A JPH04235111A (en) | 1991-01-11 | 1991-01-11 | Cosmetic |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3002103A JPH04235111A (en) | 1991-01-11 | 1991-01-11 | Cosmetic |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH04235111A true JPH04235111A (en) | 1992-08-24 |
Family
ID=11520011
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3002103A Pending JPH04235111A (en) | 1991-01-11 | 1991-01-11 | Cosmetic |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH04235111A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002026940A1 (en) * | 2000-09-26 | 2002-04-04 | The Beta Peptide Foundation Pty Ltd | Compositions and methods for delaying, preventing, rejuvenating or reversing senescence in cells |
JP2009120564A (en) * | 2007-11-16 | 2009-06-04 | Maruha Nichiro Foods Inc | Hyaluronic acid production-promoting substance |
ITBS20100197A1 (en) * | 2010-12-06 | 2012-06-07 | Paoli Ambrosi Gianfranco De | NEW COMPOUND OF CARNOSINE |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60116617A (en) * | 1983-11-30 | 1985-06-24 | Shiseido Co Ltd | Cosmetic |
JPS62209010A (en) * | 1986-03-10 | 1987-09-14 | Kobayashi Kooc:Kk | Cosmetic |
JPS63298509A (en) * | 1987-05-29 | 1988-12-06 | Yaskawa Electric Mfg Co Ltd | Controller for process monitoring device |
JPH02221213A (en) * | 1989-02-23 | 1990-09-04 | Nagai Kinuko | Skin cosmetic |
-
1991
- 1991-01-11 JP JP3002103A patent/JPH04235111A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60116617A (en) * | 1983-11-30 | 1985-06-24 | Shiseido Co Ltd | Cosmetic |
JPS62209010A (en) * | 1986-03-10 | 1987-09-14 | Kobayashi Kooc:Kk | Cosmetic |
JPS63298509A (en) * | 1987-05-29 | 1988-12-06 | Yaskawa Electric Mfg Co Ltd | Controller for process monitoring device |
JPH02221213A (en) * | 1989-02-23 | 1990-09-04 | Nagai Kinuko | Skin cosmetic |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002026940A1 (en) * | 2000-09-26 | 2002-04-04 | The Beta Peptide Foundation Pty Ltd | Compositions and methods for delaying, preventing, rejuvenating or reversing senescence in cells |
JP2009120564A (en) * | 2007-11-16 | 2009-06-04 | Maruha Nichiro Foods Inc | Hyaluronic acid production-promoting substance |
ITBS20100197A1 (en) * | 2010-12-06 | 2012-06-07 | Paoli Ambrosi Gianfranco De | NEW COMPOUND OF CARNOSINE |
WO2012076961A3 (en) * | 2010-12-06 | 2012-11-01 | Gianfranco De Paoli Ambrosi | Carnosine - hyaluronic acid mixtures and their use |
CN103282032A (en) * | 2010-12-06 | 2013-09-04 | 詹弗兰科·德保利安布罗西 | Carnosine-hyaluronic acid mixtures and their use |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3483988B2 (en) | Skin preparation | |
JP2886591B2 (en) | Cosmetics | |
JP2000256398A (en) | Collagen originated from fish skin and cosmetic containing the collagen | |
JP3758794B2 (en) | Collagen production promoter and anti-aging skin external preparation containing the same | |
JP3449624B2 (en) | Method for producing cosmetics and swallow fossil extract | |
JP3172753B2 (en) | Biological hyaluronic acid synthesis promoter | |
JP2000355515A (en) | Cosmetic composition | |
JP3784442B2 (en) | Topical skin preparation | |
JPH04235111A (en) | Cosmetic | |
JP4828077B2 (en) | Topical skin preparation | |
JP4887050B2 (en) | Inadequate keratinization inhibitor, pore reducing agent | |
JPH05301812A (en) | Skin external preparation | |
JP2000344697A (en) | Long-chain branched alcohol and cosmetic and external preparation produced by using the alcohol | |
JPH10279418A (en) | Preparation for external use for skin | |
JPH0665039A (en) | Cosmetic | |
JPH09176030A (en) | Medicine for stimulating secretion of sebum | |
JPH10147514A (en) | Cosmetic | |
JPS58128310A (en) | Skin conditioner | |
JP2780805B2 (en) | New skin external preparation composition | |
JP2000247825A (en) | Cosmetic and external preparation | |
JPH10203920A (en) | Skin preparation for external use | |
JP2000344651A (en) | Skin lotion | |
JP3516792B2 (en) | External preparation for skin | |
JP2000178165A (en) | Skin preparation for external use | |
JPH10273413A (en) | Skin preparation for external use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20000118 |